爱康医疗2024年报

目錄 2468232954環境、社會及管治報告71獨立核數師報告162綜合損益及其他全面收益表169綜合財務狀況表170綜合權益變動表172綜合現金流量表173綜合財務報表附註175 公司資料財務摘要董事長報告書管理層討論與分析董事會及高級管理層董事會報告企業管治報告 提名委員會（「提名委員會」） 董事 註冊辦事處 Conyers Trust Company (Cayman) LimitedCricket SquareHutchins DrivePO Box 2681Grand CaymanKY1-1111Cayman Islands 2024618Eric Wang20246 18 中國人民共和國（「中國」）主要營業地點及總部 102 公司秘書 20248 302024830 授權代表 香港主要營業地點 20248 302024830 33191928 審計委員會（「審計委員會」） 審計師 108 薪酬委員會（「薪酬委員會」） 香港法律顧問 1018-19 主要銀行 開曼群島股份過戶登記總處 Conyers Trust Company (Cayman) LimitedCricket SquareHutchins DriveP.O. Box 2681Grand Cayman KY1-1111Cayman Islands 香港股份過戶登記分處 上市資料及股份代號 MUFG Corporate Markets Pty Limited28161601 1789.HK 公司網址 www.ak-medical.net 本公司愛康醫療董事董事會本集團我們20241231報告期間 202412311,346.4202323.1%202420241231273.9202350.4% 20243D1,346.423.1%273.950.4% 2024 2022V T S2023 2025 20241051260 3DICOS20093D3D2014ICOS 李志疆 業務概覽及展望 2024521國家醫保局6,28158.168%10%2024123129 90%3DiCOS2024 202412311,346.423.1%273.950.4% iCOS 3D 20093D3D3DACT 2014iCOSiCOS數字骨科平台2022VTS20232024 iCOS3DiCOS2VTSiCOS2024 iCOS3D 髖膝關節植入物業務 3D 2024 202412311,134.225.8% 脊柱與創傷植入物業務 3D3D 20243D10810 1231127.33.3% 數字骨科定製產品及服務 2024VTS20249VTSVTS20241231VTS1,000 2024iCOS 51.320233.5% 海外業務 2024JRIAK242024510122024VTS2024 2024274.3202320.8% 20243D 20241231NMPA K3 CT/MRI/XiCOS 3D 2012ITI 常規關節脊柱業務推廣 202420241510 20243D3D3D3D3D4 數字骨科能力建設項目 20232024VTS Tutorials 2024VTS12VTSVTS820301002024121,000 202412K32024K3K3 絲路健康國際交流項目 202312202452024105126040 20242025 前景 iCOS股東 10153D3D3D JRI50 財務回顧 202412311,346.4202323.1%202420241231273.9202350.4% (1)3D(2)3D(3)3D(4)VTS(5) 202412311,346.4202323.1% 3D 20241231729.120231231590.423.5%20241231405.120231231311.430.1% 2024 3D20241231127.320231231123.33.3%20243D10810 VTS2024123151.32023123149.63.5%20242024VTS 2024202333.519.32.5%1.8% 20241231274.32023123120.8%2024202412311,072.120231231866.723.7% 20241231538.220231231419.428.3% 20241231808.220231231674.519.8% 2024123160.0%2023123161.7%1.7% 2024123116.72023123126.49.72024 20241231240.920231231218.810.1% 20241231143.920231231133.47.9% 20241231139.220231231137.11.5%2024 2024123119.02023123119.60.6 2024123145.92023123149.06.4%2023 20241231352.2610.756.88.01,027.720231231757.3 202412311,581.6202312311,476.6105.0 202412313.4202312311.9 20241231206.4(i)(ii)(iii) 20241231196.320231231184.122.97.52023123118.85.2226.7 2024123160.42023123121.417.72023123132.32.5%-3.0%202412313.0%202312312.2% 2024123120231231 20241231 20241231 20241231954202312311,05220241231254.920231231255.0 20241231 20241231 董事 李志疆先生572015717201646 20201572120157282016315200911112016328Bright AK Limited愛康醫療北京2018352018410JRIOrthopedics Limited20035202012292003519881999 2014819987 張斌女士572015717201646 20200912Bright AK Limited19882002CT 20161219888 張朝陽先生552015717201646 1020157212015728201573020163282020420035202012241988920033 20161120016 趙曉紅女士47201622920164620181221 1020204242020520202012282018410JRI Orthopedics Limited2010920194201412201612201646202012282004820099200911272015227 2004620016 王國瑋博士632016229201646 1020118OrbiMedAdvisors LLCGaush Meditech Ltd.2407)688506)2006420117WI Harper Group20103201273002062019712105)201956603990202042421382021813300685 1995619867 江智武先生CESGA®, FSA, FCCA, CPA, FCG, HKFCG, FHKIoD & MHKSI4920171117 200365802210 199761998300215199831999101999102007122008520203008932017122024408313 (i)(EFFAS)ESGESG(ii)(SASB) ESG(i)(ACCA)(ii)(HKICPA)(iii)(CGI)(HKCGI)(iv)(HKIoD)(v)(HKSI)199712 李澍榮博士6020171117 2 0 1 27G r e a tB o n u sDevelopmentLimited2010720131MedtronicWeigao Orthopedic DeviceCompanyLimited20071120081G2000 (Apparel) Limited200172006 2018320202SBS(Swiss Business School)198612(Chaminade University of Honolulu)1986520053Stryker Advanced Leadership Academy19994Hewlett-PackardManagement AcademyWorldwideAssociation of Business Coaches202281 高偉博士582024618 H1601.HKH1456.HKA601456.SH3602360.HK 2013201420202022202320151120181120111120196600270.SH20161201962017120198200312016120598.HK2010120196 198971993119996199610 20241231 劉愛國女士512019961200310200310201272017120201229 2017919987 王彩梅女士5224201010 2001320109 20096 梁堃女士40202012200772014720147201612201612 孫漢忠先生542021505200123002319 1992 馬榮堃女士3120248302019972018220199(Financial PR Group) 20165 (i)EricWang2024618(ii)20246182024630 D212 20241231 主要業務 16 業務回顧及主要財務表現 202412311,346.4202323.1%273.9202350.4% 822 420241231 主要風險及不確定因素 2024 主要關係 環保政策 英國20241231 遵守法律及法規 2024 捐款 202412317,400,000 業績及股息 20241231 202412317.220234.520256272025718 暫停辦理股份過戶登記手續 (a)2025618202561320256182025612MUFGCorporate Markets PtyLimited28161601 (b)202562520256272025624MUFGCorporateMarkets Pty Limited28161601 財務概要 5 物業、廠房及設備 13 借款 2024123160.417.7 資產抵押 20241231196.322.97.5226.7 主要客戶及供應商 2024123117.2%63.04.7% 77.4%123.846% 202412315% 股本 2024123130 儲備 20241231 20241231946.4 董事 20241231 20246 18Eric Wang2024618 84 董事服務合約 薪酬政策 20241231 910 100% 獨立非執行董事的獨立性 上市規則3.1320241231 董事於